Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- DIAGNOSTIC NEWS IN BRIEF
December 17, 2001
- 17th Quality Reevaluation to Start on 18 Mono-drugs, 8 Combinations
December 17, 2001
- Sephora to Withdraw from Japan
December 17, 2001
- Quality Reevaluation Completed for Drugs Accounting for 60% of Total Market
December 17, 2001
- Matsumotokiyoshi: Sales, Net Profits Increase 11%, 46.1%, Respectively
December 17, 2001
- REGULATORY NEWS IN BRIEF
December 17, 2001
- Kraft: Dispensing Business Boosts Sales by 16.8%
December 17, 2001
- FTC Issues Recommendation to 9 Wholesalers in the Tohoku Region
December 17, 2001
- BioZak Japan Established to Supply Mfg. Technology on Hepatitis C Agents
December 17, 2001
- Fukuda Denshi to Manufacture ECG in China
December 17, 2001
- Eli Lilly, Chugai to Dissolve Their JV
December 17, 2001
- Hitachi Medical Develops Lung Cancer Diagnosis Support System
December 17, 2001
- EPS: CRO, SMO Businesses Boost Sales by 42.2%
December 17, 2001
- ISI Provides Medical, Pharmaceutical Literature Search Services
December 17, 2001
- AstraZeneca to Launch New Corticosteroid Inhaler, Pulmicort Turbuhaler
December 17, 2001
- JAPANESE LANGUAGE BOOKS
December 17, 2001
- Differences in Culture Prevent Tanabe, Taisho from Getting Together
December 17, 2001
- Chugai to Become Member of Roche Group
December 17, 2001
- BUSINESS NEWS IN BRIEF
December 10, 2001
- Inabata to Gear Up Drug, Health Food Business
December 10, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…